Literature DB >> 18772853

Surveillance for cancers associated with tobacco use--United States, 1999-2004.

Sherri L Stewart1, Cheryll J Cardinez, Lisa C Richardson, Leslie Norman, Rachel Kaufmann, Terry F Pechacek, Trevor D Thompson, Hannah K Weir, Susan A Sabatino.   

Abstract

PROBLEM/CONDITION: Tobacco use is the leading preventable cause of disease and premature death in the United States. The 2004 Surgeon General report found convincing evidence for a direct causal relationship between tobacco use and the following cancers: lung and bronchial, laryngeal, oral cavity and pharyngeal, esophageal, stomach, pancreatic, kidney and renal pelvis, urinary bladder, and cervical cancers and acute myelogenous leukemia (AML). This report provides state-level cancer incidence data and recent trends for cancers associated with tobacco use. Because information on tobacco use was not available in the databases of the National Program of Cancer Registries (NPCR) and Surveillance, Epidemiology, and End Results (SEER) program, cases of cancer included in this report might or might not be in persons who used tobacco; however, the cancer types included in this report are those defined by the U.S. Surgeon General as having a direct causal relationship with tobacco use (i.e., referred to as tobacco-related cancer in this report). These data are important for initiation, monitoring, and evaluation of targeted tobacco prevention and control measures. REPORTING PERIOD COVERED: 1999--2004. DESCRIPTION OF SYSTEMS: Data were obtained from cancer registries affiliated with CDC's NPCR and the National Cancer Institute's SEER program; combined, these data cover approximately 92% of the U.S. population. Combined data from the NPCR and SEER programs provide the best source of information on population-based cancer incidence for the nation and are the only source of information for 41 states (including the District of Columbia) with cancer surveillance programs that are funded solely by NPCR. This report provides age-adjusted cancer incidence rates by demographic and geographic characteristics, percentage distributions for tumor characteristics, and trends in cancer incidence by sex.
RESULTS: Approximately 2.4 million cases of tobacco-related cancer were diagnosed during 1999--2004. Age-adjusted incidence rates ranged from 4.0 per 100,000 persons (for AML) to 69.4 (for lung and bronchial cancer). High rates occurred among men, black and non-Hispanic populations, and older adults. Higher incidence rates of lung and laryngeal cancer occurred in the South compared with other regions, particularly the West, consistent with high smoking patterns in the South.
INTERPRETATION: The high rates of tobacco-related cancer observed among men, blacks, non-Hispanics, and older adults reflect overall demographic patterns of cancer incidence in the United States and reflect patterns of tobacco use. PUBLIC HEALTH ACTION: The findings in this report emphasize the need for ongoing surveillance and reporting to monitor cancer incidence trends, identify populations at greatest risk for developing cancer related to tobacco use, and evaluate the effectiveness of targeted tobacco control programs and policies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18772853

Source DB:  PubMed          Journal:  MMWR Surveill Summ        ISSN: 1545-8636


  27 in total

1.  Worksite Cancer Prevention Activities in the National Comprehensive Cancer Control Program.

Authors:  Zachary Nahmias; Julie S Townsend; Antonio Neri; Sherri L Stewart
Journal:  J Community Health       Date:  2016-08

Review 2.  How cigarette smoke skews immune responses to promote infection, lung disease and cancer.

Authors:  Martin R Stämpfli; Gary P Anderson
Journal:  Nat Rev Immunol       Date:  2009-05       Impact factor: 53.106

3.  The disproportionate cost of smoking for African Americans in California.

Authors:  Wendy Max; Hai-Yen Sung; Lue-Yen Tucker; Brad Stark
Journal:  Am J Public Health       Date:  2010-01       Impact factor: 9.308

4.  Smoking and Smoking Cessation Among Persons with Tobacco- and Non-tobacco-Associated Cancers.

Authors:  M Shayne Gallaway; Bin Huang; Quan Chen; Thomas C Tucker; Jaclyn K McDowell; Eric Durbin; Sherri L Stewart; Eric Tai
Journal:  J Community Health       Date:  2019-06

Review 5.  Interplay between smoking-induced genotoxicity and altered signaling in pancreatic carcinogenesis.

Authors:  Navneet Momi; Sukhwinder Kaur; Moorthy P Ponnusamy; Sushil Kumar; Uwe A Wittel; Surinder K Batra
Journal:  Carcinogenesis       Date:  2012-05-23       Impact factor: 4.944

6.  Persistent cigarette smoking and other tobacco use after a tobacco-related cancer diagnosis.

Authors:  J Michael Underwood; Julie S Townsend; Eric Tai; Arica White; Shane P Davis; Temeika L Fairley
Journal:  J Cancer Surviv       Date:  2012-06-16       Impact factor: 4.442

7.  Cost of Tobacco-related Cancer Hospitalizations in the U.S., 2014.

Authors:  Eric W Tai; Gery P Guy; C Brooke Steele; S Jane Henley; Michael S Gallaway; Lisa C Richardson
Journal:  Am J Prev Med       Date:  2018-02-01       Impact factor: 5.043

8.  Celebrating 10 years of the National Comprehensive Cancer Control Program, 1998 to 2008.

Authors:  Anne Major; Sherri L Stewart
Journal:  Prev Chronic Dis       Date:  2009-09-15       Impact factor: 2.830

9.  DNA damage in exfoliated cells and histopathological alterations in the urinary tract of mice exposed to cigarette smoke and treated with chemopreventive agents.

Authors:  Sebastiano La Maestra; Rosanna T Micale; Silvio De Flora; Francesco D'Agostini; Gancho Ganchev; Marietta Iltcheva; Nikolay Petkov; Vernon E Steele; Roumen Balansky
Journal:  Carcinogenesis       Date:  2012-10-05       Impact factor: 4.944

10.  The role of tobacco in cancer health disparities.

Authors:  Jennifer Irvin Vidrine; Lorraine R Reitzel; David W Wetter
Journal:  Curr Oncol Rep       Date:  2009-11       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.